세계의 동물용 약물감시 시장 보고서(2025년)
Veterinary Pharmacovigilance Global Market Report 2025
상품코드 : 1717354
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 약물감시 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 예측 기간의 주요 동향으로는 디지털 보고 시스템의 채택, 짐승 의료용 원격 의료 서비스 확대, 데이터 보안을 위한 블록체인 통합, 클라우드 약물감시 플랫폼 개발 등이 있습니다.

동물의 건강과 의약품 제품에 대한 수요 증가는 동물용 약물감시 시장의 성장을 가속할 것으로 예측됩니다. 이러한 수요 증가는 반려동물의 사육수 증가, 수의학의 진보, 가축의 생산성을 높일 필요성 등이 배경에 있습니다. 부작용의 모니터링과 평가, 규제 준수의 철저를 통해 의약품의 안전성과 유효성을 확보함으로써 반려동물 케어에서 중요한 역할을 하고 있습니다. 예를 들어, 2024년 3월 에스토니아 의약품청(Ravimiamet)은 2023년 동물용 의약품 부문이 2022년 1,740만 유로에 비해 6.9% 성장하여 1,860만 유로를 기록했다고 보고했습니다.

동물용 약물감시 부문의 주요 기업은 유해사례보고(REAS)나 안전성 보고서 작성 등의 데이터 분석에 있어서의 개발을 통해 규제 프레임워크의 강화에 주력하고 있습니다. 예를 들어 2024년 8월, 멕시코 농업 농촌 개발성은 새로운 동물용 약물감시 시스템을 시작했습니다. 이 시스템은 멕시코에서 동물 의약품의 안전성, 품질 및 효능을 보장하는 것을 목표로 합니다. 제품과 관련된 위험을 식별, 평가 및 완화합니다. 이 시스템에는 부작용을 문서화하고 효능, 잔류 한계 및 환경에 미치는 영향과 같은 문제를 모니터링하기 위한 동물용 약물감시 가이드(REAS)가 포함되어 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

Veterinary pharmacovigilance is the field focused on detecting, assessing, understanding, and preventing adverse effects or other drug-related issues in animals. It involves monitoring and evaluating the safety and efficacy of veterinary medicines after their approval. The aim is to ensure that the benefits of these medicines outweigh the risks, thus promoting animal health and welfare while also protecting human health and the environment.

The main types of veterinary pharmacovigilance are in-house and outsourced. In-house pharmacovigilance involves the monitoring and assessment of adverse drug reactions and safety-related data conducted by the pharmaceutical or veterinary company itself. This includes the use of software and services for products such as biologics and anti-infectives. The scope covers various animal types, including companion animals, livestock, and others. End users of these services include veterinary hospitals, veterinary companies, and academic and research institutes.

The veterinary pharmacovigilance market research report is one of a series of new reports from the business research company that provides veterinary pharmacovigilance market statistics, including veterinary pharmacovigilance industry global market size, regional shares, competitors with an veterinary pharmacovigilance market share, detailed veterinary pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmacovigilance industry. This veterinary pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary pharmacovigilance market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to increasing awareness of animal health, growth in the companion animal population, rising demand for livestock products, expanding veterinary services, and higher prevalence of zoonotic diseases.

The veterinary pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $1.5 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. The growth in the forecast period can be attributed to increasing pet ownership and spending, rising veterinary expenditure, growing focus on animal welfare, expansion of telemedicine in veterinary services, and higher demand for personalized veterinary care. Major trends in the forecast period include adoption of digital reporting systems, expansion of telehealth services for veterinary care, integration of blockchain for data security, and development of cloud-based pharmacovigilance platforms.

The increasing demand for animal health and medicinal products is projected to drive the growth of the veterinary pharmacovigilance market. Animal health and medicine products include food, medications, and grooming items designed to support the health and well-being of pets. This growing demand is fueled by rising pet ownership, advances in veterinary medicine, and the need to boost livestock productivity. Moreover, greater awareness of animal welfare and a higher incidence of animal diseases are contributing to this surge. Veterinary pharmacovigilance plays a crucial role in pet care by ensuring the safety and effectiveness of medications through monitoring and assessing adverse effects and ensuring regulatory compliance. For example, the Republic of Estonia's Agency of Medicines (Ravimiamet) reported in March 2024 that the veterinary medicinal products sector grew by 6.9% in 2023, reaching 18.6 million euros, compared to 17.4 million euros in 2022. This growth in demand for animal health and medicinal products is expected to drive the veterinary pharmacovigilance market.

Key companies in the veterinary pharmacovigilance sector are concentrating on enhancing regulatory frameworks through developments in data analytics, such as adverse event reporting (REAS) and safety report preparation. These processes involve documenting and analyzing harmful reactions to veterinary drugs to assess safety and ensure compliance with regulatory standards. For instance, in August 2024, Mexico's Ministry of Agriculture and Rural Development launched a new veterinary pharmacovigilance system. Developed by SENASICA, this system aims to ensure the safety, quality, and efficacy of veterinary drugs in Mexico. It gathers data on adverse reactions from various stakeholders, including pharmaceutical companies, distributors, veterinary hospitals, and veterinarians, to identify, assess, and mitigate risks associated with these medications. The system includes the veterinary pharmacovigilance guide (REAS) for documenting adverse reactions and monitoring issues such as efficacy, residue limits, and environmental impacts.

In January 2024, Veterinary Pharmaceutical Solutions, a US-based company specializing in veterinary services, acquired Diamond Animal Health, Inc. for an undisclosed amount. This acquisition is intended to expand Veterinary Pharmaceutical Solutions' product range, enhance its research and development capabilities, and improve operational efficiencies within the animal health industry. Diamond Animal Health Inc. is a US-based contract manufacturing and research firm offering regulatory affairs consulting, a component of veterinary pharmacovigilance services.

Major companies operating in the veterinary pharmacovigilance market are Accenture PLC, Zoetis Inc, Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Covetrus Inc, IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac SA, Merck Animal Health, Huvepharma EOOD, Norbrook Laboratories Ltd, ProPharma Group, ArisGlobal LLC, PQE Group, Chanelle Pharma Group Ltd, Clinvet International, Ennov SAS, Sarjen Systems Pvt. Ltd, PharSafer Associates Ltd, Medfiles Oy, Azierta Contract Science Support Consulting, Knoell Germany GmbH, Triveritas Ltd, Leon Research, Biologit, Indivirtus Group

North America was the largest region in the veterinary pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary pharmacovigilance market consists of revenues earned by entities by providing services such as monitoring adverse drug reactions, assessing medication safety, collecting and analyzing safety data, conducting risk management, and ensuring regulatory compliance for veterinary medicines. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary pharmacovigilance market also includes sales of databases, reporting systems, safety assessment tools, and monitoring devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Pharmacovigilance Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Pharmacovigilance Market Characteristics

3. Veterinary Pharmacovigilance Market Trends And Strategies

4. Veterinary Pharmacovigilance Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Pharmacovigilance Growth Analysis And Strategic Analysis Framework

6. Veterinary Pharmacovigilance Market Segmentation

7. Veterinary Pharmacovigilance Market Regional And Country Analysis

8. Asia-Pacific Veterinary Pharmacovigilance Market

9. China Veterinary Pharmacovigilance Market

10. India Veterinary Pharmacovigilance Market

11. Japan Veterinary Pharmacovigilance Market

12. Australia Veterinary Pharmacovigilance Market

13. Indonesia Veterinary Pharmacovigilance Market

14. South Korea Veterinary Pharmacovigilance Market

15. Western Europe Veterinary Pharmacovigilance Market

16. UK Veterinary Pharmacovigilance Market

17. Germany Veterinary Pharmacovigilance Market

18. France Veterinary Pharmacovigilance Market

19. Italy Veterinary Pharmacovigilance Market

20. Spain Veterinary Pharmacovigilance Market

21. Eastern Europe Veterinary Pharmacovigilance Market

22. Russia Veterinary Pharmacovigilance Market

23. North America Veterinary Pharmacovigilance Market

24. USA Veterinary Pharmacovigilance Market

25. Canada Veterinary Pharmacovigilance Market

26. South America Veterinary Pharmacovigilance Market

27. Brazil Veterinary Pharmacovigilance Market

28. Middle East Veterinary Pharmacovigilance Market

29. Africa Veterinary Pharmacovigilance Market

30. Veterinary Pharmacovigilance Market Competitive Landscape And Company Profiles

31. Veterinary Pharmacovigilance Market Other Major And Innovative Companies

32. Global Veterinary Pharmacovigilance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Pharmacovigilance Market

34. Recent Developments In The Veterinary Pharmacovigilance Market

35. Veterinary Pharmacovigilance Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기